Results 31 to 40 of about 830,959 (241)

Revolutionizing radical prostatectomy - a comparative study of traditional and modern automated surgical techniques

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose: Prostate cancer is a common malignancy seen worldwide and second most common cancer among Polish men as well as globally. The symptoms of prostate cancer depend on severity of the cancer. Prostate cancer diagnosis is typically
Katarzyna Rojek   +9 more
doaj   +1 more source

Aptamer‐Engineered Liposomal Platform Enables in Situ cDC1 Vaccination to Potentiate Immunotherapy in Prostate Cancer

open access: yesAdvanced Science, EarlyView.
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang   +8 more
wiley   +1 more source

The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens

open access: yesBMC Cancer, 2018
Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided ...
Zhipeng Mai   +7 more
doaj   +1 more source

An Expertise Transfer Framework For Autonomous Surgical Assistance

open access: yesAdvanced Science, EarlyView.
This study introduces an expertise transfer framework for procedure‐spanning autonomous surgical assistance. By emulating expert logic through hierarchical perception, attention modeling, and knowledge graph‐based decision‐making, the system provides near‐expert surgical view assistance.
Yuan Gao   +12 more
wiley   +1 more source

The Contemporary Role of Salvage Radical Prostatectomy in the Management of Recurrent Prostate Cancer: An Up-to-Date Review

open access: yesLife
Prostate cancer is the second most common cancer among men, with many treatment modalities available for patients, such as radical prostatectomy, external beam radiotherapy, brachytherapy, high-intensity focused ultrasound, cryotherapy, electroporation ...
Stamatios Katsimperis   +15 more
doaj   +1 more source

Risk factors for increased intraocular pressure and eye damage during robotic-assisted prostatectomy

open access: yesВестник анестезиологии и реаниматологии, 2021
Prostate cancer remains the most common urologic malignancy, and robotic-assisted radical prostatectomy makes the most effective treatment option.
I. I. Lutfarakhmanov   +3 more
doaj   +1 more source

Interpreting a Radical Prostatectomy Report

open access: yes, 2019
Worldwide, clinically detected prostate cancer is the second most common malignancy, with an estimated 1.1 million new cases in 2012. Standard active treatments for prostate cancer include radiotherapy and/or radical prostatectomy (RP) (for clinically ...
Yasemin Yuyucu Karabulut
core   +1 more source

Quality of Life after Radical Prostatectomy: A Longitudinal Study [PDF]

open access: yes, 2023
Background: Men with prostate cancer who undergo radical prostatectomy experience a decrease in quality of life, often related to sexual disfunction and urinary incontinence.
Ana Belén Subirón-Valera   +28 more
core   +1 more source

The VCPIP1‐UBE3A Deubiquitination‐Ubiquitination Cascade Contributes to Castration‐Resistant Prostate Cancer Progression

open access: yesAdvanced Science, EarlyView.
VCIPIP1 emerges as a molecular link between protein stability and prostate cancer progression. By deubiquitinating and stabilizing UBE3A, VCIPIP1 promotes p53 degradation and progression to castration‐resistant prostate cancer. Elevated VCIPIP1 expression is associated with shorter castration‐resistant prostate cancer–free survival, highlighting the ...
Fei Lin   +9 more
wiley   +1 more source

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer. [PDF]

open access: yes, 2008
Contains fulltext : 69173.pdf (Publisher’s version ) (Open Access)OBJECTIVES: Previous studies suggest that maximum tumor diameter (MTD) is a predictor of recurrence in prostate cancer (PC).
C. A. Hulsbergen-vandeKaa   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy